Format

Send to

Choose Destination
J Reprod Med. 2004 Jun;49(6):473-6.

Role of obesity in the surgical management of advanced-stage ovarian cancer.

Author information

1
Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. awolfberg@partners.org

Abstract

OBJECTIVE:

To assess whether obese women with advanced-stage ovarian cancer undergoing primary cytoreduction surgery were at increased risk of suboptimal cytoreduction and complications during the operative and postoperative period as compared to nonobese women.

STUDY DESIGN:

A retrospective, case-control study of all cases of advanced-stage epithelial ovarian cancer managed surgically at Johns Hopkins Hospital between January 1, 1990, and December 31, 1999.

RESULTS:

Obese patients were as likely as nonobese patients to undergo optimal cytoreduction at surgery. Obese patients were more likely than nonobese patients to be high-risk anesthesia candidates and more likely than nonobese patients to have tumors >20 cm at surgery. Obese patients were not at greater risk of surgical or postoperative complications than were nonobese patients.

CONCLUSION:

Obesity is not a risk factor for suboptimal surgical management of advanced-stage ovarian cancer.

PMID:
15283057
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center